Delivery Order SPE2DR25D3103-SPE2DR26F9Z85
- Not listed
- The Defense Logistics Agency awarded a $4,588.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 ml pharmaceutical product, with a completion date of January 9, 2026. The award was made on a competitive, non-set-aside basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,862.33 for Actemra ActPen 162 mg/0.9 mL injectable medication, with an ultimate completion date of December 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $2,310.51 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 mL injectable medication. This is a firm fixed-price delivery order with an ultimate completion date of December 19, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $64,762.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL auto-injectors. The contract was competitively awarded without set-aside restrictions and carries an ultimate completion date of January 9, 2026. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,006.96 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 mL injectable medication. The contract, awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $19,985.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Actemra Actpen 162 mg/0.9 mL auto-injectors. The order, which represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 6, 2026. This delivery order was competitively awarded without...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,058.52 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL injectable medication. Issued on August 14, 2025, with an ultimate completion date of August 15, 2025, this firm fixed-price contract requires performance at the company's Conshohocken, Pennsylvania location. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $4,644.40 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL auto-injector pens. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of August 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $6,922.53 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL auto-injectors. This competitively awarded, firm fixed-price contract was executed on June 17, 2025, with an ultimate completion date of June 18, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $5,967.40 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 ml pharmaceutical product on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract is a firm fixed price delivery order with no set-aside designation, and performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9Z85Delivery Order
The Defense Logistics Agency awarded a $3,003.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Actemra ActPen 162 mg/0.9 ml injectable medication. This is a non-set-aside competitive award with a completion date of January 23, 2026, and performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs for military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs worldwide. The contract demonstrates AmerisourceBergen's capability to fulfill federal medical supply requirements through open competition, with awards typically structured as firm fixed-price transactions ranging from minimal to substantial order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 1/21/26 |